title: Nebivolol and valsartan: useful treatment for hypertension?
authors.affiliation: Division of Clinical Pathophysiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, MP14, 1011 Lausanne, Switzerland. Electronic address: bernard.waeber@chuv.ch.
authors.forename: Bernard
authors.initials: B
authors.lastname: Waeber
authors.affiliation: Division of Clinical Pathophysiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, MP14, 1011 Lausanne, Switzerland.
authors.forename: François
authors.initials: F
authors.lastname: Feihl
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001578:Benzopyrans / Q000008:administration & dosage*; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D000068577:Nebivolol; D013777:Tetrazoles / Q000008:administration & dosage*; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000068756:Valsartan
chemical_list: D000959:Antihypertensive Agents; D001578:Benzopyrans; D004983:Ethanolamines; D013777:Tetrazoles; D000068577:Nebivolol; D000068756:Valsartan; D014633:Valine